Descripción

Baseline characteristics of metabolic syndrome patients enrolled in the resveratrol, piperine, and alpha-tocopherol supplementation trial are summarized.

Figure 1

Source Paper

Supplementation with Resveratrol, Piperine and Alpha-Tocopherol Decreases Chronic Inflammation in a Cluster of Older Adults with Metabolic Syndrome.

Nutrients (2020)

PMID: 33076345

DOI: 10.3390/nu12103149

Cite This Figure

![Figure 1: Baseline characteristics of metabolic syndrome patients enrolled in the resveratrol, piperine, and alpha-tocopherol supplementation trial are summarized.]()

> Source: Raúl Francisco Pastor et al. "Supplementation with Resveratrol, Piperine and Alpha-Tocopherol Decreases Chroni." *Nutrients*, 2020. PMID: [33076345](https://pubmed.ncbi.nlm.nih.gov/33076345/)

<figure>
  <img src="" alt="Baseline characteristics of metabolic syndrome patients enrolled in the resveratrol, piperine, and alpha-tocopherol supplementation trial are summarized." />
  <figcaption>Figure 1. Baseline characteristics of metabolic syndrome patients enrolled in the resveratrol, piperine, and alpha-tocopherol supplementation trial are summarized.<br>  Source: Raúl Francisco Pastor et al. "Supplementation with Resveratrol, Piperine and Alpha-Tocopherol Decreases Chroni." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33076345/">33076345</a></figcaption>
</figure>

Evidencia relacionada

Resveratrol para Chronic Inflammation

Calificación C · 5 estudios